A detailed history of Hudson Bay Capital Management LP transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 493,548 shares of KOD stock, worth $2.73 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
493,548
Previous 538,374 8.33%
Holding current value
$2.73 Million
Previous $1.27 Million 1.82%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.2 - $3.25 $98,617 - $145,684
-44,826 Reduced 8.33%
493,548 $1.29 Million
Q2 2024

Aug 14, 2024

SELL
$2.29 - $4.48 $198,373 - $388,084
-86,626 Reduced 13.86%
538,374 $1.27 Million
Q1 2024

May 15, 2024

BUY
$3.01 - $7.45 $1.88 Million - $4.66 Million
625,000 New
625,000 $3.29 Million
Q2 2022

Aug 12, 2022

SELL
$5.04 - $9.48 $100,800 - $189,600
-20,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.09 - $89.45 $141,800 - $1.79 Million
20,000 New
20,000 $154,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $288M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.